Chinese drug regulators have approved the world’s first inhalable Covid-19 vaccine, made by Tianjin-based manufacturer CanSino Biologics, boosting the company’s share price by seven percent.
The needle-free vaccine can be stored and administered more easily than intramuscular jabs and can trigger strong antibody responses, according to a Lancet report published in July 2021.